12 Health Care Stocks Moving In Wednesday's After-Market Session
Portfolio Pulse from Benzinga Insights
The article highlights the performance of 12 healthcare stocks during Wednesday's after-market session. Notable gainers include Anitra (AZTR), Oragenics (OGEN), PACS Group (PACS), MultiPlan (MPLN), Nanoviricides (NNVC), and Calidi Biotherapeutics (CLDI). On the losing side, Matinas BioPharma (MTNB), Theriva Biologics (TOVX), Concord Medical Services (CCM), Emergent BioSolutions (EBS), Senseonics Holdings (SENS), and Vicarious Surgical (RBOT) saw declines.
June 05, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Anitra (AZTR) shares increased by 6.5% to $0.18, with a market cap of $5.1 million.
The significant price increase suggests positive sentiment or news, likely leading to short-term gains.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
Calidi Biotherapeutics (CLDI) shares increased by 0.95% to $0.21, with a market cap of $10.7 million.
The price increase indicates positive sentiment, suggesting potential short-term gains.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 60
POSITIVE IMPACT
MultiPlan (MPLN) shares moved upwards by 3.49% to $0.45, with a market cap of $290.3 million.
The price increase indicates positive sentiment, suggesting potential short-term gains.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Nanoviricides (NNVC) stock moved upwards by 2.01% to $2.48, with a market cap of $29.2 million.
The price increase suggests positive market reaction, likely leading to short-term gains.
CONFIDENCE 80
IMPORTANCE 55
RELEVANCE 65
POSITIVE IMPACT
Oragenics (OGEN) shares increased by 4.24% to $2.04, with a market cap of $9.1 million.
The price increase indicates positive market reaction, suggesting potential short-term gains.
CONFIDENCE 85
IMPORTANCE 55
RELEVANCE 70
POSITIVE IMPACT
PACS Group (PACS) shares rose 3.95% to $31.52, with a market cap of $4.8 billion.
The price increase suggests strong market confidence, likely leading to short-term gains.
CONFIDENCE 90
IMPORTANCE 65
RELEVANCE 75
NEGATIVE IMPACT
Concord Medical Services (CCM) stock fell 2.66% to $1.1, with a market cap of $47.7 million.
The price decrease suggests negative sentiment, likely leading to short-term losses.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 60
NEGATIVE IMPACT
Emergent BioSolutions (EBS) shares fell 2.4% to $6.51, with a market cap of $341.1 million.
The price decrease indicates negative market reaction, suggesting potential short-term losses.
CONFIDENCE 80
IMPORTANCE 55
RELEVANCE 65
NEGATIVE IMPACT
Matinas BioPharma (MTNB) shares decreased by 4.2% to $0.15, with a market cap of $38.7 million.
The price decrease suggests negative sentiment or news, likely leading to short-term losses.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Vicarious Surgical (RBOT) stock declined by 2.16% to $0.35, with a market cap of $61.6 million.
The price decrease indicates negative market reaction, suggesting potential short-term losses.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 60
NEGATIVE IMPACT
Senseonics Holdings (SENS) stock declined by 2.28% to $0.43, with a market cap of $228.2 million.
The price decrease suggests negative sentiment, likely leading to short-term losses.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 60
NEGATIVE IMPACT
Theriva Biologics (TOVX) stock declined by 3.19% to $0.27, with a market cap of $4.6 million.
The price decrease indicates negative market reaction, suggesting potential short-term losses.
CONFIDENCE 80
IMPORTANCE 55
RELEVANCE 65